Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
Yurong Peng(Central South University), Fang Wu(Central South University), Yue Pan(Shandong University), Chaoyue Xiao(Central South University), Yue Zeng(Shandong University), Guoqing Li(Central South University), Junqi Liu(University of Minnesota), Yingzhe Zhang(Central South University), Zhuo Li(Central South University), Yucheng Fu(Ruijin Hospital), Yahui Su(Central South University)
Cited by 15
Related Papers
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
|Clinical Epigenetics|2021|253
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
|Nature Medicine|2024|116
The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
|Frontiers in Oncology|2021|111
Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients
|Diabetes Research and Clinical Practice|2014|92
Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
|Frontiers in Cell and Developmental Biology|2021|78